Aytu BioPharma, Inc.AYTUNASDAQ
LOADING
|||
Switch Symbol:
Operating Income Contraction
Trending lower, above historical average, structural decline.
Left:
||||
Profit from core business operations before interest and taxes
Latest
$-7.83M
↑ 73% above average
Average (9y)
$-29.48M
Historical baseline
Range
High:$-1.59M
Low:$-109.91M
CAGR
-10.7%
Structural decline
| Period | Value | Change |
|---|---|---|
| 2025 | $-7.83M | -392.0% |
| 2024 | $-1.59M | +90.7% |
| 2023 | $-17.07M | +84.5% |
| 2022 | $-109.91M | -86.7% |
| 2021 | $-58.87M | -178.6% |
| 2020 | $-21.13M | -25.4% |
| 2019 | $-16.85M | +14.5% |
| 2018 | $-19.70M | +2.1% |
| 2017 | $-20.13M | +7.3% |
| 2016 | $-21.70M | - |